Stocks and Investing
Stocks and Investing
Fri, September 6, 2024
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Thu, September 5, 2024
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Ami Fadia Reiterated (AXSM) at Strong Buy and Held Target at $130 on, Sep 5th, 2024
Ami Fadia of Needham, Reiterated "Axsome Therapeutics, Inc." (AXSM) at Strong Buy and Held Target at $130 on, Sep 5th, 2024.
Ami has made no other calls on AXSM in the last 4 months.
There are 8 other peers that have a rating on AXSM. Out of the 8 peers that are also analyzing AXSM, 0 agree with Ami's Rating of Hold.
These are the ratings of the 8 analyists that currently disagree with Ami
- Cerena Chen of "Wells Fargo" Initiated at Buy and Held Target at $140 on, Tuesday, September 3rd, 2024
- Ashwani Verma of "UBS" Maintained at Strong Buy with Decreased Target to $105 on, Tuesday, August 6th, 2024
- Jason Gerberry of "B of A Securities" Upgraded from Hold to Strong Buy and Increased Target to $106 on, Tuesday, August 6th, 2024
- Leonid Timashev of "RBC Capital" Maintained at Buy with Decreased Target to $130 on, Tuesday, August 6th, 2024
- Charles Duncan of "Cantor Fitzgerald" Reiterated at Buy and Held Target at $107 on, Friday, July 26th, 2024
- Graig Suvannavejh of "Mizuho" Reiterated at Strong Buy and Held Target at $106 on, Wednesday, June 12th, 2024
- David Hoang of "Citigroup" Maintained at Strong Buy with Decreased Target to $125 on, Tuesday, May 7th, 2024
- Joel Beatty of "Baird" Maintained at Buy with Increased Target to $112 on, Tuesday, May 7th, 2024
Contributing Sources